Biotech's perfect storm.
The global financial crisis has hit biotech companies hard both in the US and Europe as venture capital dries up. Finding new sources of long-term financing for translating research into new therapeutics will be essential for maintaining innovation and new drug development by biotech companies.
Karberg
Sascha
S
D001709:Biotechnology / Q000191:economics* / Q000639:trends; D002202:Capital Financing; D005060:Europe; D017048:Health Care Costs; D014481:United States